These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34537446)

  • 1. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
    Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
    Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(WR)
    Zoghebi K; Aliabadi HM; Tiwari RK; Parang K
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
    Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
    Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
    Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
    Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
    Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
    Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters.
    El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
    Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
    Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.
    Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q
    J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
    Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
    J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
    Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
    Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells.
    Ai S; Jia T; Ai W; Duan J; Liu Y; Chen J; Liu X; Yang F; Tian Y; Huang Z
    Br J Pharmacol; 2013 Apr; 168(7):1719-35. PubMed ID: 23146125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice.
    Shankaranarayanan JS; Kanwar JR; Al-Juhaishi AJ; Kanwar RK
    Sci Rep; 2016 Aug; 6():32062. PubMed ID: 27576789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
    Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate.
    Chhikara BS; Mandal D; Parang K
    J Med Chem; 2012 Feb; 55(4):1500-10. PubMed ID: 22276998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate.
    Burns KE; Delehanty JB
    Int J Pharm; 2018 Jul; 545(1-2):64-73. PubMed ID: 29709616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
    Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.